Cargando…
Implementation of smoking signature as an improved biomarker predicting the response to immunotherapy
Autores principales: | Yang, Haitang, Ma, Wenyan, Yao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825653/ https://www.ncbi.nlm.nih.gov/pubmed/35242635 http://dx.doi.org/10.21037/tlcr-22-28 |
Ejemplares similares
-
Smoking signature as a biomarker for immunotherapy
por: Li, Mengqian, et al.
Publicado: (2022) -
Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients
por: Yang, Haitang, et al.
Publicado: (2021) -
Gene signature related to cancer stem cells and fibroblasts of stem‐like gastric cancer predicts immunotherapy response
por: Sung, Ji‐Yong, et al.
Publicado: (2023) -
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
por: Bertucci, François, et al.
Publicado: (2023) -
KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumors
por: Zhang, Rui, et al.
Publicado: (2020)